AMWL Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

52.71M

-25.77%

-1.780

-35.74%

57.82M

-13.48%

-1.335

+12.18%

58.01M

-18.17%

-1.262

+1.75%

Estimates Revision

The market is revising Downward the revenue expectations for American Well Corporation (AMWL) for FY2025, with the revenue forecasts being adjusted by -0.39% over the past three months. During the same period, the stock price has changed by -11.17%.

Revenue Estimates for FY2025

Revise Downward

-0.39%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.58%

In Past 3 Month

Stock Price

Go Down

-11.17%

In Past 3 Month

5 Analyst Rating

Wall Street analysts forecast AMWL stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AMWL is 8.83 USD with a low forecast of 7.00 USD and a high forecast of 12.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

1 Buy

4 Hold

0 Sell

Hold

Current: 0.000

Low

7.00

Averages

8.83

High

12.00

Current: 0.000

Low

7.00

Averages

8.83

High

12.00

Morgan Stanley

Equal Weight

downgrade

2025-12-18

Reason

Morgan Stanley

Price Target

2025-12-18

downgrade

Equal Weight

Reason

Morgan Stanley lowered the firm's price target on Amwell to $6 from $10.50 and keeps an Equal Weight rating on the shares. For healthcare technology and providers, the firm sees an "attractive backdrop for alpha-generation opportunities" in 2026, the analyst tells investors. Meanwhile, managed care stocks have underperformed in 2025 and are facing "another year of unprecedented policy, reimbursement, and utilization headwinds," the analyst added in a year-ahead outlook note for the Healthcare Services group.

Stifel

Hold

downgrade

$8 -> $6

2025-11-05

Reason

Stifel

Price Target

$8 -> $6

2025-11-05

downgrade

Hold

Reason

Stifel lowered the firm's price target on Amwell to $6 from $8 and keeps a Hold rating on the shares. While the company's execution on cost takeout and the DHA contract launch have been positive, visibility remains limited on several fronts, the analyst tells investors in a post-earnings note.

TD Cowen

Hold

downgrade

$10 -> $7

2025-11-05

Reason

TD Cowen

Price Target

$10 -> $7

2025-11-05

downgrade

Hold

Reason

TD Cowen lowered the firm's price target on Amwell to $7 from $10 and keeps a Hold rating on the shares. The firm said its 3Q adj. EBITDA beat/raise and reiterating '26 CF breakeven target are positive for cost reduction priorities.

TD Cowen

Hold

downgrade

$12 -> $10

2025-08-06

Reason

TD Cowen

Price Target

$12 -> $10

2025-08-06

downgrade

Hold

Reason

TD Cowen lowered the firm's price target on Amwell to $10 from $12 and keeps a Hold rating on the shares. The firm updated its model following Q2 results but said while the DHA extension is a positive, its reduced scope which excludes Behavioral health and automated care, is an unfortunate development.

Piper Sandler

Neutral

downgrade

$10 -> $8

2025-05-23

Reason

Piper Sandler

Price Target

$10 -> $8

2025-05-23

downgrade

Neutral

Reason

Piper Sandler lowered the firm's price target on Amwell to $8 from $10 and keeps a Neutral rating on the shares following a positive Q1 print where the company beat revenue and adjusted EBITDA guidance and reaffirmed the 2025 outlook. As of early April, scheduled visits are live across the entire DHA; a considerable achievement delivered on time and on budget, the firm notes. DHA patient and provider satisfaction levels are running in excess of 90.0%. However, due to a leadership transition at the DHA, enterprise-wide deployments of automated programs and digital behavioral health planned for Q2 are expected to be delayed until Q3, Piper says.

UBS

Kevin Caliendo

Neutral

downgrade

$12 -> $9

2025-05-08

Reason

UBS

Kevin Caliendo

Price Target

$12 -> $9

2025-05-08

downgrade

Neutral

Reason

UBS analyst Kevin Caliendo lowered the firm's price target on Amwell to $9 from $12 and keeps a Neutral rating on the shares.

Valuation Metrics

The current forward P/E ratio for American Well Corp (AMWL.N) is -0.88, compared to its 5-year average forward P/E of -12.04. For a more detailed relative valuation and DCF analysis to assess American Well Corp 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

-12.04

Current PE

-0.88

Overvalued PE

12.98

Undervalued PE

-37.06

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

-3.44

Current EV/EBITDA

2.88

Overvalued EV/EBITDA

5.57

Undervalued EV/EBITDA

-12.46

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

3.98

Current PS

0.35

Overvalued PS

9.80

Undervalued PS

-1.84

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 141.83% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 141.83% over the last month.

Sold

Bought

AMWL News & Events

Events Timeline

No data

News

9.5

2025-11-05NASDAQ.COM

American Well (AMWL) Q3 Earnings: Analyzing Key Metrics Against Estimates

9.5

2025-10-27Newsfilter

Amwell® to Announce Q3 2025 Financial Results; Executives to Participate in Upcoming Investor Conferences

2.0

2025-08-13NASDAQ.COM

Hims & Hers Stock Plunges 21.3% in 3 Months: Time to Hold or Exit?

People Also Watch

Frequently Asked Questions

What is American Well Corp (AMWL) stock price today?

The current price of AMWL is 5.17 USD — it has increased 0 % in the last trading day.

What is American Well Corp (AMWL)'s business?

American Well Corporation operates a hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver access to more affordable quality care. It offers a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. The Amwell Converge platform offers data architecture and video capabilities, flexibility and scalability, as well as a user experience focused on the needs of patients, members and providers. For health systems, its enterprise platform enables provider-to-provider virtual care for use cases ranging from stroke to virtual nursing and e-sitting. Its Amwell Carepoint devices enable healthcare providers to leverage proprietary carts and transform existing tablets and TVs into digital access points in clinical settings, helping to address personnel shortages and access limitations.

What is the price predicton of AMWL Stock?

What is American Well Corp (AMWL)'s revenue for the last quarter?

American Well Corp revenue for the last quarter amounts to 56.29M USD, decreased -7.80 % YoY.

What is American Well Corp (AMWL)'s earnings per share (EPS) for the last quarter?

American Well Corp. EPS for the last quarter amounts to -2.00 USD, decreased -30.31 % YoY.

What changes have occurred in the market's expectations for American Well Corp (AMWL)'s fundamentals?

How many employees does American Well Corp (AMWL). have?

American Well Corp (AMWL) has 877 emplpoyees as of January 10 2026.

What is American Well Corp (AMWL) market cap?

Today AMWL has the market capitalization of 84.64M USD.